Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cost-effectiveness of laparoscopy as diagnostic tool before primary cytoreductive surgery in ovarian cancer.

van de Vrie R, van Meurs HS, Rutten MJ, Naaktgeboren CA, Opmeer BC, Gaarenstroom KN, van Gorp T, Ter Brugge HG, Hofhuis W, Schreuder HWR, Arts HJG, Zusterzeel PLM, Pijnenborg JMA, van Haaften M, Engelen MJA, Boss EA, Vos MC, Gerestein KG, Schutter EMJ, Kenter GG, Bossuyt PMM, Mol BW, Buist MR.

Gynecol Oncol. 2017 Sep;146(3):449-456. doi: 10.1016/j.ygyno.2017.06.019. Epub 2017 Jun 20.

PMID:
28645428
2.

Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.

Rutten MJ, van Meurs HS, van de Vrie R, Gaarenstroom KN, Naaktgeboren CA, van Gorp T, Ter Brugge HG, Hofhuis W, Schreuder HW, Arts HJ, Zusterzeel PL, Pijnenborg JM, van Haaften M, Fons G, Engelen MJ, Boss EA, Vos MC, Gerestein KG, Schutter EM, Opmeer BC, Spijkerboer AM, Bossuyt PM, Mol BW, Kenter GG, Buist MR.

J Clin Oncol. 2017 Feb 20;35(6):613-621. doi: 10.1200/JCO.2016.69.2962. Epub 2016 Dec 28.

PMID:
28029317
3.

Molecularly Defined Adult Granulosa Cell Tumor of the Ovary: The Clinical Phenotype.

McConechy MK, Färkkilä A, Horlings HM, Talhouk A, Unkila-Kallio L, van Meurs HS, Yang W, Rozenberg N, Andersson N, Zaby K, Bryk S, Bützow R, Halfwerk JB, Hooijer GK, van de Vijver MJ, Buist MR, Kenter GG, Brucker SY, Krämer B, Staebler A, Bleeker MC, Heikinheimo M, Kommoss S, Blake Gilks C, Anttonen M, Huntsman DG.

J Natl Cancer Inst. 2016 Jun 13;108(11). pii: djw134. doi: 10.1093/jnci/djw134. Print 2016 Nov.

4.

The HysNiche trial: hysteroscopic resection of uterine caesarean scar defect (niche) in patients with abnormal bleeding, a randomised controlled trial.

Vervoort AJ, Van der Voet LF, Witmer M, Thurkow AL, Radder CM, van Kesteren PJ, Quartero HW, Kuchenbecker WK, Bongers MY, Geomini PM, de Vleeschouwer LH, van Hooff MH, van Vliet HA, Veersema S, Renes WB, van Meurs HS, Bosmans J, Oude Rengerink K, Brölmann HA, Mol BW, Huirne JA.

BMC Womens Health. 2015 Nov 12;15:103. doi: 10.1186/s12905-015-0260-8.

5.

Evaluation of response to hormone therapy in patients with measurable adult granulosa cell tumors of the ovary.

van Meurs HS, van der Velden J, Buist MR, van Driel WJ, Kenter GG, van Lonkhuijzen LR.

Acta Obstet Gynecol Scand. 2015 Nov;94(11):1269-75. doi: 10.1111/aogs.12720. Epub 2015 Sep 15.

PMID:
26230362
6.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators.

Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.

7.

Development and internal validation of a prognostic model to predict recurrence free survival in patients with adult granulosa cell tumors of the ovary.

van Meurs HS, Schuit E, Horlings HM, van der Velden J, van Driel WJ, Mol BW, Kenter GG, Buist MR.

Gynecol Oncol. 2014 Sep;134(3):498-504. doi: 10.1016/j.ygyno.2014.06.021. Epub 2014 Jun 28.

PMID:
24983647
8.

Hormone therapy in ovarian granulosa cell tumors: a systematic review.

van Meurs HS, van Lonkhuijzen LR, Limpens J, van der Velden J, Buist MR.

Gynecol Oncol. 2014 Jul;134(1):196-205. doi: 10.1016/j.ygyno.2014.03.573. Epub 2014 Apr 5. Review.

PMID:
24713548
9.

Effectiveness of chemotherapy in measurable granulosa cell tumors: a retrospective study and review of literature.

van Meurs HS, Buist MR, Westermann AM, Sonke GS, Kenter GG, van der Velden J.

Int J Gynecol Cancer. 2014 Mar;24(3):496-505. doi: 10.1097/IGC.0000000000000077. Review.

PMID:
24469325
10.

The incidence of endometrial hyperplasia and cancer in 1031 patients with a granulosa cell tumor of the ovary: long-term follow-up in a population-based cohort study.

van Meurs HS, Bleeker MC, van der Velden J, Overbeek LI, Kenter GG, Buist MR.

Int J Gynecol Cancer. 2013 Oct;23(8):1417-22. doi: 10.1097/IGC.0b013e3182a57fb4.

PMID:
24257556
11.

Levonorgestrel releasing intrauterine system (Mirena) versus endometrial ablation (Novasure) in women with heavy menstrual bleeding: a multicentre randomised controlled trial.

Herman MC, van den Brink MJ, Geomini PM, van Meurs HS, Huirne JA, Eising HP, Timmermans A, Pijnenborg JM, Klinkert ER, Coppus SF, Nieboer TE, Catshoek R, van der Voet LF, van Eijndhoven HW, Graziosi GC, Veersema S, van Kesteren PJ, Langenveld J, Smeets NA, van Vliet HA, van der Steeg JW, Lisman-van Leeuwen Y, Dekker JH, Mol BW, Berger MY, Bongers MY.

BMC Womens Health. 2013 Aug 8;13:32. doi: 10.1186/1472-6874-13-32.

12.

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial.

van Meurs HS, Tajik P, Hof MH, Vergote I, Kenter GG, Mol BW, Buist MR, Bossuyt PM.

Eur J Cancer. 2013 Oct;49(15):3191-201. doi: 10.1016/j.ejca.2013.06.013. Epub 2013 Jul 11.

PMID:
23850170
13.

Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.

Roobol MJ, Kranse R, Bangma CH, van Leenders AG, Blijenberg BG, van Schaik RH, Kirkels WJ, Otto SJ, van der Kwast TH, de Koning HJ, Schröder FH; ERSPC Rotterdam Study Group.

Eur Urol. 2013 Oct;64(4):530-9. doi: 10.1016/j.eururo.2013.05.030. Epub 2013 May 25.

PMID:
23759326
14.

Surgical versus expectant management in women with an incomplete evacuation of the uterus after treatment with misoprostol for miscarriage: the MisoREST trial.

Verschoor MA, Lemmers M, Bossuyt PM, Graziosi GC, Hajenius PJ, Hendriks DJ, van Hooff MA, van Meurs HS, Opmeer BC, van Tulder MW, Bouwma L, Catshoek R, Geomini P, Klinkert ER, Langenveld J, Nieboer TE, van der Ploeg JM, Radder CM, Spinder T, van der Voet LF, Mol BW, Huirne JA, Ankum WM.

BMC Pregnancy Childbirth. 2013 May 2;13:102. doi: 10.1186/1471-2393-13-102.

15.

Prostate-cancer mortality at 11 years of follow-up.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.

N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135. Erratum in: N Engl J Med. 2012 May 31;366(22):2137.

16.

Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study.

Rutten MJ, Gaarenstroom KN, Van Gorp T, van Meurs HS, Arts HJ, Bossuyt PM, Ter Brugge HG, Hermans RH, Opmeer BC, Pijnenborg JM, Schreuder HW, Schutter EM, Spijkerboer AM, Wensveen CW, Zusterzeel P, Mol BW, Kenter GG, Buist MR.

BMC Cancer. 2012 Jan 20;12:31. doi: 10.1186/1471-2407-12-31.

17.

A uterine leiomyoma in which a leiomyosarcoma with osteoclast-like giant cells and a metastasis of a ductal breast carcinoma are present.

van Meurs HS, Dieles JJ, Stel HV.

Ann Diagn Pathol. 2012 Jan;16(1):67-70. doi: 10.1016/j.anndiagpath.2010.11.010. Epub 2011 Jan 8.

PMID:
21216642
18.

Screening and prostate-cancer mortality in a randomized European study.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.

N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.

19.

Frequency of pelvic lymph node metastases and parametrial involvement in stage IA2 cervical cancer: a population-based study and literature review.

van Meurs H, Visser O, Buist MR, Ten Kate FJ, van der Velden J.

Int J Gynecol Cancer. 2009 Jan;19(1):21-6. doi: 10.1111/IGC.0b013e318197f3ef.

PMID:
19258936
20.

Ultrasound protocols to measure carotid intima-media thickness: a post-hoc analysis of the OPAL study.

Dogan S, Plantinga Y, Evans GW, Meijer R, Grobbee DE, Bots ML; OPAL investigators.

Curr Med Res Opin. 2009 Jan;25(1):109-22. doi: 10.1185/03007990802589727 .

PMID:
19210144

Supplemental Content

Loading ...
Support Center